{"transactions":[{"id":804506,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-20T22:09:35.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":10410,"price":49.5745,"value":516070.545,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units (\"RSUs\") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 47,835 shares of common stock, 122,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions."}],"balance_after":619856,"source":{"system":"sec-edgar","filing":"0001104659-26-045582","document":"tm2612274-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926045582/tm2612274-2_4seq1.xml","form_type":"4"}},{"id":909983,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:12:17.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":47021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") subject to time-based vesting conditions. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2027 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 33,245 shares of common stock, 147,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions."}],"balance_after":630266,"source":{"system":"sec-edgar","filing":"0001104659-26-013586","document":"tm266077-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926013586/tm266077-7_4seq1.xml","form_type":"4"}},{"id":938518,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-16T00:58:31.000Z","date":"2026-01-13","kind":"sale","planned":false,"acquired":false,"shares":16755,"price":42.7,"value":715438.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units subject to performance-and time-based vesting conditions (\"PSUs\"). The sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Each PSU represents the contingent right to receive upon vesting of the PSU, one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"(continued) The shares vested pursuant to awards that were granted on April 27, 2025. 50,000 shares subject to this PSU vested on January 12, 2026, with an additional 50,000 shares scheduled to vest on April 27, 2027 and the remaining shares vesting in tranches of a combination of performance-based vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four year, provided the Reporting Person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"33,245 shares of common stock, 100,000 restricted stock units and 450,000 PSUs."}],"balance_after":583245,"source":{"system":"sec-edgar","filing":"0001104659-26-004224","document":"tm263352-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926004224/tm263352-4_4seq1.xml","form_type":"4"}},{"id":1021324,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.775,"expiration_date":"2031-08-08","underlying":"Ordinary Shares","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1021323,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":240000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.9338,"expiration_date":"2034-04-28","underlying":"Ordinary Shares","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1021322,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":96000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":2.67,"expiration_date":"2033-04-27","underlying":"Ordinary Shares","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1021321,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":384,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.5038,"expiration_date":"2032-04-27","underlying":"Ordinary Shares","underlying_shares":384},"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1021320,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":72000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1021319,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1021318,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":true,"shares":72000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."}],"balance_after":72000,"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1021317,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-08T20:36:31.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":94112,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents Ordinary Shares of the Issuer acquired from the Reporting Person by means of a scheme of arrangement (the \"Scheme of Arrangement\") under Part 26 of the UK Companies Act 2006, pursuant to a transaction agreement, dated as of July 8, 2025 (the \"Transaction Agreement\"), by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\") and Vol Holdings LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (\"Bidco\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Scheme of Arrangement (the \"Effective Time\"), each holder of the Scheme Shares (as defined in the Scheme of Arrangement) became entitled to receive $13.375 in cash per Scheme Share, without interest and net of any applicable withholding taxes. Because each ADS represents a beneficial ownership interest in eight (8) Ordinary Shares of the Issuer, holders of ADSs as of the Effective Time became entitled to receive eight (8) times the foregoing cash amount, or $107 in cash, without interest and net of any applicable withholding taxes, per ADS (the \"ADS Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-097954","document":"tm2528014-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925097954/tm2528014-7_4seq1.xml","form_type":"4"}},{"id":1074229,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-06T00:17:32.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":72000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-074382","document":"tm2522566-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925074382/tm2522566-2_4seq1.xml","form_type":"4"}},{"id":1074228,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-06T00:17:32.000Z","date":"2025-08-01","kind":"sale","planned":false,"acquired":false,"shares":4328,"price":13.1437,"value":56885.9336,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the Reporting Person's tax withholding obligation upon the vesting of the restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of 94,112 Ordinary Shares represented by 11,764 ADSs."}],"balance_after":94112,"source":{"system":"sec-edgar","filing":"0001104659-25-074382","document":"tm2522566-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925074382/tm2522566-2_4seq1.xml","form_type":"4"}},{"id":1074227,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-06T00:17:32.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":98440,"source":{"system":"sec-edgar","filing":"0001104659-25-074382","document":"tm2522566-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925074382/tm2522566-2_4seq1.xml","form_type":"4"}},{"id":1136812,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-05-22T20:06:12.000Z","date":"2025-05-20","kind":"exercise","planned":true,"acquired":false,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."}],"balance_after":384,"derivative":{"exercise_price":0.5038,"expiration_date":"2032-04-27","underlying":"Ordinary Shares","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001104659-25-051986","document":"tm2515898-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051986/tm2515898-2_4seq1.xml","form_type":"4"}},{"id":1136811,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T20:06:12.000Z","date":"2025-05-20","kind":"sale","planned":true,"acquired":false,"shares":160000,"price":9.3933,"value":1502928.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $9.375 to $9.4263, inclusive (or $75.00 to $75.41 per ADS, inclusive). The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of 74,440 Ordinary Shares represented by 9,305 ADSs."}],"balance_after":74440,"source":{"system":"sec-edgar","filing":"0001104659-25-051986","document":"tm2515898-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051986/tm2515898-2_4seq1.xml","form_type":"4"}},{"id":1136810,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T20:06:12.000Z","date":"2025-05-20","kind":"exercise","planned":true,"acquired":true,"shares":160000,"price":0.5038,"value":80608.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":234440,"source":{"system":"sec-edgar","filing":"0001104659-25-051986","document":"tm2515898-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051986/tm2515898-2_4seq1.xml","form_type":"4"}},{"id":1136809,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-05-22T20:05:12.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":false,"shares":39616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"security","element":"securityTitle","label":"F5","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."}],"balance_after":160384,"derivative":{"exercise_price":0.5038,"expiration_date":"2032-04-27","underlying":"Ordinary Shares","underlying_shares":39616},"source":{"system":"sec-edgar","filing":"0001104659-25-051979","document":"tm2515898-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051979/tm2515898-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-01"}},{"id":1136808,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-05-22T20:05:12.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":false,"shares":120384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"security","element":"securityTitle","label":"F5","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."}],"balance_after":0,"derivative":{"exercise_price":1.7,"expiration_date":"2027-04-26","underlying":"Ordinary Shares","underlying_shares":120384},"source":{"system":"sec-edgar","filing":"0001104659-25-051979","document":"tm2515898-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051979/tm2515898-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-01"}},{"id":1136807,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T20:05:12.000Z","date":"2025-04-29","kind":"sale","planned":true,"acquired":false,"shares":39616,"price":8.9208,"value":353406.4128,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"Reported securities are represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of 74,440 Ordinary Shares represented by 9,305 ADSs."}],"balance_after":74440,"source":{"system":"sec-edgar","filing":"0001104659-25-051979","document":"tm2515898-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051979/tm2515898-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-01"}},{"id":1136806,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T20:05:12.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":true,"shares":39616,"price":0.5038,"value":19958.5408,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"Reported securities are represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."}],"balance_after":114056,"source":{"system":"sec-edgar","filing":"0001104659-25-051979","document":"tm2515898-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051979/tm2515898-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-01"}},{"id":1136805,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T20:05:12.000Z","date":"2025-04-29","kind":"sale","planned":true,"acquired":false,"shares":120384,"price":8.9208,"value":1073921.5872,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"Reported securities are represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."}],"balance_after":74440,"source":{"system":"sec-edgar","filing":"0001104659-25-051979","document":"tm2515898-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051979/tm2515898-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-01"}},{"id":1136804,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T20:05:12.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":true,"shares":120384,"price":1.7,"value":204652.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"Reported securities are represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares (\"ADSs\") instead of Ordinary Shares."}],"balance_after":194824,"source":{"system":"sec-edgar","filing":"0001104659-25-051979","document":"tm2515898-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925051979/tm2515898-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-01"}},{"id":1157424,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-06T21:01:06.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":110067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest on April 27, 2026, with the remainder vesting in twelve equal quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date."}],"balance_after":110067,"derivative":{"exercise_price":32.91,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":110067},"source":{"system":"sec-edgar","filing":"0001104659-25-045114","document":"tm2513936-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465925045114/tm2513936-2_4seq1.xml","form_type":"4"}},{"id":1162337,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-05-02T00:53:10.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":false,"shares":4952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":195048,"derivative":{"exercise_price":0.5038,"expiration_date":"2032-04-27","underlying":"Ordinary Shares","underlying_shares":4952},"source":{"system":"sec-edgar","filing":"0001104659-25-043644","document":"tm2513834-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925043644/tm2513834-1_4seq1.xml","form_type":"4"}},{"id":1162336,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-05-02T00:53:10.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":false,"shares":15048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":80952,"derivative":{"exercise_price":1.7,"expiration_date":"2027-04-26","underlying":"Ordinary Shares","underlying_shares":15048},"source":{"system":"sec-edgar","filing":"0001104659-25-043644","document":"tm2513834-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925043644/tm2513834-1_4seq1.xml","form_type":"4"}},{"id":1162335,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-02T00:53:10.000Z","date":"2025-04-29","kind":"sale","planned":true,"acquired":false,"shares":4952,"price":8.9208,"value":44175.8016,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of 74,440 Ordinary Shares represented by 9,305 ADSs."}],"balance_after":74440,"source":{"system":"sec-edgar","filing":"0001104659-25-043644","document":"tm2513834-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925043644/tm2513834-1_4seq1.xml","form_type":"4"}},{"id":1162334,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-02T00:53:10.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":true,"shares":4952,"price":0.5038,"value":2494.8176,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":79392,"source":{"system":"sec-edgar","filing":"0001104659-25-043644","document":"tm2513834-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925043644/tm2513834-1_4seq1.xml","form_type":"4"}},{"id":1162333,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-02T00:53:10.000Z","date":"2025-04-29","kind":"sale","planned":true,"acquired":false,"shares":15048,"price":8.9208,"value":134240.1984,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price."}],"balance_after":74440,"source":{"system":"sec-edgar","filing":"0001104659-25-043644","document":"tm2513834-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925043644/tm2513834-1_4seq1.xml","form_type":"4"}},{"id":1162332,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-02T00:53:10.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":true,"shares":15048,"price":1.7,"value":25581.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":89488,"source":{"system":"sec-edgar","filing":"0001104659-25-043644","document":"tm2513834-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925043644/tm2513834-1_4seq1.xml","form_type":"4"}},{"id":1163927,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-29T22:05:20.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance based RSUs subject to performance- and time-based vesting conditions (the \"PSUs\"). The amount reported herein represents the maximum number of shares of the Issuer's common stock that may be issued under this award. The shares subject to this PSU vest in tranches of a combination of performance vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four years, provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0001104659-25-041454","document":"tm2513505-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465925041454/tm2513505-4_4seq1.xml","form_type":"4"}},{"id":1163926,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-29T22:05:20.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") subject to time-based vesting conditions. Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on April 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001104659-25-041454","document":"tm2513505-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465925041454/tm2513505-4_4seq1.xml","form_type":"4"}},{"id":1163785,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-04-29T21:17:53.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."}],"balance_after":96000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001104659-25-041402","document":"tm2513544-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465925041402/tm2513544-9_4seq1.xml","form_type":"4"}},{"id":1249708,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-24T21:15:10.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":303,"price":10.0758,"value":3052.9674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.06 to $10.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":49129,"source":{"system":"sec-edgar","filing":"0000950170-25-025634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025025634/ownership.xml","form_type":"4"}},{"id":1294522,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-27T21:11:26.000Z","date":"2025-01-23","kind":"sale","planned":false,"acquired":false,"shares":13,"price":9.9402,"value":129.2226,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.81 to $10.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects a 1-for-23 reverse split of the Issuer's Common Stock effected on January 16, 2025."}],"balance_after":49432,"source":{"system":"sec-edgar","filing":"0000950170-25-009197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025009197/ownership.xml","form_type":"4"}},{"id":1294521,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-27T21:11:26.000Z","date":"2025-01-23","kind":"sale","planned":false,"acquired":false,"shares":116,"price":9.4538,"value":1096.6408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.81 to $9.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects a 1-for-23 reverse split of the Issuer's Common Stock effected on January 16, 2025."}],"balance_after":49445,"source":{"system":"sec-edgar","filing":"0000950170-25-009197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025009197/ownership.xml","form_type":"4"}},{"id":1304348,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-13T21:15:05.000Z","date":"2025-01-10","kind":"sale","planned":false,"acquired":false,"shares":979,"price":0.4401,"value":430.8579,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.44 to $0.462. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1139915,"source":{"system":"sec-edgar","filing":"0000950170-25-004832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025004832/ownership.xml","form_type":"4"}},{"id":1357309,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-20T21:15:06.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":3186,"price":0.5485,"value":1747.521,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.545 to $0.572. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1140894,"source":{"system":"sec-edgar","filing":"0000950170-24-129259","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024129259/ownership.xml","form_type":"4"}},{"id":1374290,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-06T21:15:09.000Z","date":"2024-11-05","kind":"sale","planned":false,"acquired":false,"shares":5136,"price":0.8649,"value":4442.1264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.856 to $0.9151. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1144080,"source":{"system":"sec-edgar","filing":"0000950170-24-122333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024122333/ownership.xml","form_type":"4"}},{"id":1382397,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-23T20:15:04.000Z","date":"2024-10-22","kind":"sale","planned":false,"acquired":false,"shares":1882,"price":0.7678,"value":1444.9996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.76 to $0.7709. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1149216,"source":{"system":"sec-edgar","filing":"0000950170-24-116648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024116648/ownership.xml","form_type":"4"}},{"id":1382396,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-23T20:15:04.000Z","date":"2024-10-21","kind":"sale","planned":false,"acquired":false,"shares":1546,"price":0.779,"value":1204.334,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7544 to $0.7964. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1151098,"source":{"system":"sec-edgar","filing":"0000950170-24-116648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024116648/ownership.xml","form_type":"4"}},{"id":1390805,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-04T20:15:07.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":940,"price":0.8148,"value":765.912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":1152644,"source":{"system":"sec-edgar","filing":"0000950170-24-112914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024112914/ownership.xml","form_type":"4"}},{"id":1427712,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-20T20:15:03.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":3159,"price":0.7595,"value":2399.2605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7373 to $0.7736. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1153584,"source":{"system":"sec-edgar","filing":"0000950170-24-099103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024099103/ownership.xml","form_type":"4"}},{"id":1438842,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-07T20:15:03.000Z","date":"2024-08-05","kind":"sale","planned":false,"acquired":false,"shares":5251,"price":0.7348,"value":3858.4348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.73 to $0.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1156743,"source":{"system":"sec-edgar","filing":"0000950170-24-092809","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024092809/ownership.xml","form_type":"4"}},{"id":1449962,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-23T20:27:24.000Z","date":"2024-07-22","kind":"sale","planned":false,"acquired":false,"shares":1858,"price":0.7392,"value":1373.4336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7330 to $0.7534. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1161994,"source":{"system":"sec-edgar","filing":"0000950170-24-085663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024085663/ownership.xml","form_type":"4"}},{"id":1449961,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-23T20:27:24.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":1542,"price":0.7501,"value":1156.6542,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7343 to $0.7925. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1163852,"source":{"system":"sec-edgar","filing":"0000950170-24-085663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024085663/ownership.xml","form_type":"4"}},{"id":1460125,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-03T20:14:43.000Z","date":"2024-07-02","kind":"sale","planned":false,"acquired":false,"shares":939,"price":0.72,"value":676.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 36,337 shares acquired under the Allovir, Inc. 2020 Employee Stock Purchase Plan on June 28, 2024."}],"balance_after":1165394,"source":{"system":"sec-edgar","filing":"0000950170-24-081518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024081518/ownership.xml","form_type":"4"}},{"id":1507234,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-21T20:33:31.000Z","date":"2024-05-17","kind":"sale","planned":false,"acquired":false,"shares":3143,"price":0.7493,"value":2355.0499,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.74 to $0.7615. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1129996,"source":{"system":"sec-edgar","filing":"0000950170-24-062978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024062978/ownership.xml","form_type":"4"}},{"id":1524814,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-07T20:15:29.000Z","date":"2024-05-03","kind":"sale","planned":false,"acquired":false,"shares":4957,"price":0.796,"value":3945.772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7801 to $0.8098. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1133139,"source":{"system":"sec-edgar","filing":"0000950170-24-054511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024054511/ownership.xml","form_type":"4"}},{"id":1532745,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2024-04-30T20:18:20.000Z","date":"2024-04-29","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% on each of July 29, 2024, October 29, 2024, January 29, 2025 and April 29, 2025."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":240000,"derivative":{"exercise_price":1.9338,"expiration_date":"2034-04-28","underlying":"Ordinary Shares","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001104659-24-054958","document":"tm2412993-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465924054958/tm2412993-5_4seq1.xml","form_type":"4"}},{"id":1536899,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-04-23T20:15:05.000Z","date":"2024-04-22","kind":"sale","planned":false,"acquired":false,"shares":1857,"price":0.75,"value":1392.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":1138096,"source":{"system":"sec-edgar","filing":"0000950170-24-046905","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024046905/ownership.xml","form_type":"4"}},{"id":1536898,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-04-23T20:15:05.000Z","date":"2024-04-19","kind":"sale","planned":false,"acquired":false,"shares":1521,"price":0.7506,"value":1141.6626,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7460 to $0.7562. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1139953,"source":{"system":"sec-edgar","filing":"0000950170-24-046905","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024046905/ownership.xml","form_type":"4"}},{"id":1547824,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-04-04T20:15:08.000Z","date":"2024-04-02","kind":"sale","planned":false,"acquired":false,"shares":885,"price":0.772,"value":683.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7513 to $0.7801. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1141474,"source":{"system":"sec-edgar","filing":"0000950170-24-041808","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024041808/ownership.xml","form_type":"4"}},{"id":1625493,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-22T21:15:47.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":2893,"price":0.6952,"value":2011.2136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.6832 to $0.7150. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1142359,"source":{"system":"sec-edgar","filing":"0000950170-24-018783","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024018783/ownership.xml","form_type":"4"}},{"id":1656832,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-06T21:46:22.000Z","date":"2024-02-05","kind":"sale","planned":false,"acquired":false,"shares":18331,"price":0.67,"value":12281.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.66 to $0.6914. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1145252,"source":{"system":"sec-edgar","filing":"0000950170-24-011778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024011778/ownership.xml","form_type":"4"}},{"id":1670976,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-25T21:15:28.000Z","date":"2024-01-23","kind":"sale","planned":false,"acquired":false,"shares":3205,"price":0.6708,"value":2149.914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.6683 to $0.6797. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1163583,"source":{"system":"sec-edgar","filing":"0000950170-24-007407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024007407/ownership.xml","form_type":"4"}},{"id":1684270,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-08T21:15:14.000Z","date":"2024-01-04","kind":"sale","planned":false,"acquired":false,"shares":961,"price":0.639,"value":614.079,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":1166788,"source":{"system":"sec-edgar","filing":"0000950170-24-002938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017024002938/ownership.xml","form_type":"4"}},{"id":1732773,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-21T22:00:41.000Z","date":"2023-11-17","kind":"sale","planned":true,"acquired":false,"shares":2490,"price":1.6311,"value":4061.439,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.61 to $1.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1167749,"source":{"system":"sec-edgar","filing":"0001209191-23-056316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123056316/doc4.xml","form_type":"4"}},{"id":1756235,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-23T21:00:11.000Z","date":"2023-10-20","kind":"sale","planned":true,"acquired":false,"shares":1475,"price":1.541,"value":2272.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.53 to $1.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1170239,"source":{"system":"sec-edgar","filing":"0001209191-23-053348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123053348/doc4.xml","form_type":"4"}},{"id":1756234,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-23T21:00:11.000Z","date":"2023-10-19","kind":"sale","planned":true,"acquired":false,"shares":1232,"price":1.58,"value":1946.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":1171714,"source":{"system":"sec-edgar","filing":"0001209191-23-053348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123053348/doc4.xml","form_type":"4"}},{"id":1764355,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-05T21:00:14.000Z","date":"2023-10-03","kind":"sale","planned":true,"acquired":false,"shares":755,"price":1.9763,"value":1492.1065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.95 to $2.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1172946,"source":{"system":"sec-edgar","filing":"0001209191-23-052228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123052228/doc4.xml","form_type":"4"}},{"id":1800843,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-21T21:00:17.000Z","date":"2023-08-17","kind":"sale","planned":true,"acquired":false,"shares":10516,"price":2.4955,"value":26242.678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.45 to $2.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1173701,"source":{"system":"sec-edgar","filing":"0001209191-23-046735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123046735/doc4.xml","form_type":"4"}},{"id":1824879,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-21T21:00:10.000Z","date":"2023-07-20","kind":"sale","planned":true,"acquired":false,"shares":1437,"price":3.3474,"value":4810.2138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.26 to $3.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1184217,"source":{"system":"sec-edgar","filing":"0001209191-23-043119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123043119/doc4.xml","form_type":"4"}},{"id":1824878,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-21T21:00:10.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":1198,"price":3.5615,"value":4266.677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.53 to $3.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1185654,"source":{"system":"sec-edgar","filing":"0001209191-23-043119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123043119/doc4.xml","form_type":"4"}},{"id":1833979,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-06T21:00:13.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":2983,"price":3.0451,"value":9083.5333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.96 to $3.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 4,780 shares acquired under the AlloVir, Inc. 2020 Employee Stock Purchase Plan on June 30, 2023."}],"balance_after":1186852,"source":{"system":"sec-edgar","filing":"0001209191-23-041582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123041582/doc4.xml","form_type":"4"}},{"id":1911198,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2023-04-28T20:18:37.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% on each of July 28, 2023, October 28, 2023, January 28, 2024 and April 28, 2024."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":96000,"derivative":{"exercise_price":2.67,"expiration_date":"2033-04-27","underlying":"Ordinary Shares","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001104659-23-052996","document":"tm2314094-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465923052996/tm2314094-4_4seq1.xml","form_type":"4"}},{"id":1915638,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-21T20:05:35.000Z","date":"2023-04-20","kind":"sale","planned":true,"acquired":false,"shares":1466,"price":3.6255,"value":5314.983,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.  These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.62 to $3.64.\nFull information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1185055,"source":{"system":"sec-edgar","filing":"0001209191-23-025128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123025128/doc4.xml","form_type":"4"}},{"id":1915637,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-21T20:05:35.000Z","date":"2023-04-19","kind":"sale","planned":true,"acquired":false,"shares":1217,"price":3.7087,"value":4513.4879,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.  These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.64 to $3.84.\nFull information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1186521,"source":{"system":"sec-edgar","filing":"0001209191-23-025128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123025128/doc4.xml","form_type":"4"}},{"id":2033139,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:00:42.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":292500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on February 2, 2024, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":1012362,"derivative":{"exercise_price":6.65,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":292500},"source":{"system":"sec-edgar","filing":"0001209191-23-006995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123006995/doc4.xml","form_type":"4"}},{"id":2033138,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-03T22:00:42.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the \"Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on February 2, 2024, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":1187738,"source":{"system":"sec-edgar","filing":"0001209191-23-006995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123006995/doc4.xml","form_type":"4"}},{"id":2048746,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-24T00:00:25.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":1426,"price":5.1438,"value":7335.0588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.05 to $5.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1030238,"source":{"system":"sec-edgar","filing":"0001209191-23-004502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123004502/doc4.xml","form_type":"4"}},{"id":2048745,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-24T00:00:25.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":5111,"price":5.0777,"value":25952.1247,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.94 to $5.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1031664,"source":{"system":"sec-edgar","filing":"0001209191-23-004502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000120919123004502/doc4.xml","form_type":"4"}},{"id":2131651,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-10-26T20:15:15.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":1449,"price":9.3607,"value":13563.6543,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1036775,"source":{"system":"sec-edgar","filing":"0000899243-22-034261","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322034261/doc4a.xml","form_type":"4/A","original_submission_date":"2022-10-24"}},{"id":2133016,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-10-24T22:28:35.000Z","date":"2022-10-19","kind":"sale","acquired":false,"shares":1449,"price":9.3607,"value":13563.6543,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1036775,"source":{"system":"sec-edgar","filing":"0000899243-22-034060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322034060/doc4.xml","form_type":"4"}},{"id":2181871,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-17T22:04:02.000Z","date":"2022-08-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the \"Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":1038224,"source":{"system":"sec-edgar","filing":"0000899243-22-029061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322029061/doc4.xml","form_type":"4"}},{"id":2199115,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-01T20:38:43.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":3253796,"price":4.61,"value":14999999.56,"ownership":{"direct":false,"nature":"By ElevateBio LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 28, 2022, ElevateBio LLC (\"ElevateBio\") acquired 3,253,796 shares of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by ElevateBio. The Reporting Person is a director and Chief Financial Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":16674766,"source":{"system":"sec-edgar","filing":"0000899243-22-027175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322027175/doc4.xml","form_type":"4"}},{"id":2203977,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-07-21T23:12:06.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":1432,"price":5.2145,"value":7467.164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.15 to $5.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":938224,"source":{"system":"sec-edgar","filing":"0000899243-22-026518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322026518/doc4.xml","form_type":"4"}},{"id":2212081,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-06T11:30:22.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":54600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of this option shall vest and become exercisable on July 1, 2023, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":54600,"derivative":{"exercise_price":4.13,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":54600},"source":{"system":"sec-edgar","filing":"0000899243-22-025234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322025234/doc4.xml","form_type":"4"}},{"id":2212080,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-07-06T11:30:22.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the \"Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on July 1, 2023, with the remainder vesting in twelve equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,623 shares acquired under the AlloVir, Inc. 2020 Employee Stock Purchase Plan on June 30, 2022."}],"balance_after":939656,"source":{"system":"sec-edgar","filing":"0000899243-22-025234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322025234/doc4.xml","form_type":"4"}},{"id":2287711,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2022-04-29T20:48:56.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% on each of July 28, 2022, October 28, 2022, January 28, 2023 and April 28, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":200000,"derivative":{"exercise_price":0.5038,"expiration_date":"2032-04-27","underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-22-053720","document":"tm2214046-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465922053720/tm2214046-5_4seq1.xml","form_type":"4"}},{"id":2291871,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-22T12:29:58.000Z","date":"2022-04-20","kind":"sale","acquired":false,"shares":1162,"price":6.6843,"value":7767.1566,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.665 to $6.6976. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":906633,"source":{"system":"sec-edgar","filing":"0000899243-22-015394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322015394/doc4.xml","form_type":"4"}},{"id":2308495,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T20:25:06.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":119162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on January 18, 2023, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":119162,"derivative":{"exercise_price":9.15,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":119162},"source":{"system":"sec-edgar","filing":"0000899243-22-013338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322013338/doc4.xml","form_type":"4"}},{"id":2308494,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T20:25:06.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":48838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the \"Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on January 18, 2023, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":907795,"source":{"system":"sec-edgar","filing":"0000899243-22-013338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322013338/doc4.xml","form_type":"4"}},{"id":2427841,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-24T21:15:11.000Z","date":"2022-01-20","kind":"sale","acquired":false,"shares":6450,"price":8.7526,"value":56454.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.49 to $9.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":858957,"source":{"system":"sec-edgar","filing":"0000899243-22-003002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924322003002/doc4.xml","form_type":"4"}},{"id":2608248,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2021-08-10T20:47:04.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% on August 9, 2021, 25% on November 1, 2021, 25% on February 1, 2022 and 25% on May 1, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":64000,"derivative":{"exercise_price":0.775,"expiration_date":"2031-08-08","underlying":"Ordinary Shares","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001104659-21-102898","document":"tm2124631-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465921102898/tm2124631-9_4seq1.xml","form_type":"4"}},{"id":2726771,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-05T21:05:53.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":10016,"price":0.8397,"value":8410.4352,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.8063 to $0.8525. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of 74,440 Ordinary Shares represented by 9,305 ADSs."}],"balance_after":74440,"source":{"system":"sec-edgar","filing":"0001104659-21-061808","document":"tm2115267-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465921061808/tm2115267-6_4seq1.xml","form_type":"4"}},{"id":2881035,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-02-04T00:11:00.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":10224,"price":0.9938,"value":10160.6112,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.99375 to $0.99625. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 29,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 3,625 ADSs); and (ii) 55,456 Ordinary Shares represented by 6,932 ADSs."}],"balance_after":84456,"source":{"system":"sec-edgar","filing":"0001104659-21-011748","document":"tm215272-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337845/000110465921011748/tm215272-5_4seq1.xml","form_type":"4"}},{"id":2900873,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-22T00:27:55.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":109200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on January 19, 2022, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":109200,"derivative":{"exercise_price":42.15,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":109200},"source":{"system":"sec-edgar","filing":"0000899243-21-002765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924321002765/doc4.xml","form_type":"4"}},{"id":2900872,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-22T00:27:55.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":58800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the \"Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on January 19, 2022, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":865407,"source":{"system":"sec-edgar","filing":"0000899243-21-002765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924321002765/doc4.xml","form_type":"4"}},{"id":3067706,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2020-08-06T01:57:04.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":20000000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by ElevateBio LLC (\"ElevateBio\"). The Reporting Person is a director and Chief Financial Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13420970},"source":{"system":"sec-edgar","filing":"0000899243-20-021588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924320021588/doc4.xml","form_type":"4"}},{"id":3067705,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-08-06T01:57:04.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":13420970,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by ElevateBio LLC (\"ElevateBio\"). The Reporting Person is a director and Chief Financial Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":13420970,"source":{"system":"sec-edgar","filing":"0000899243-20-021588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924320021588/doc4.xml","form_type":"4"}},{"id":3072596,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":51945,"kind":"person","name":"Sinha Vikas","position":1,"cik":"0001337845","reported_name":"Sinha Vikas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-31T22:40:57.000Z","date":"2020-07-29","kind":"grant","acquired":true,"shares":436900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":436900,"derivative":{"exercise_price":17,"expiration_date":"2030-07-29","underlying":"Common Stock","underlying_shares":436900},"source":{"system":"sec-edgar","filing":"0000899243-20-020925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000089924320020925/doc4.xml","form_type":"4"}}]}